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Abstract T regulator lymphocytes (Tregs) play a key role
in the maintenance of immune tolerance and in the de-
velopment of autoimmune diseases. Expression of Foxp3 is
specific for Tregs, and can be used for the identification of
these cells. This study investigated the variations of Tregs
Foxp3? in the kidney biopsies inflammatory infiltrate of
different lupus nephritis classes compared to that of ANCA
glomerulonephritis, acute tubulointerstitial nephritis and
nephroangiosclerosis. Sections of paraffin-embedded tissue
have been stained by immunohistochemistry with anti-CD3
and anti-FoxP3 antibodies. We find that the ratio of
FoxP3?/CD3? cells is significantly lower in patients with
lupus nephritis class IV and in patients with vasculitides
than in the course of nephroangiosclerosis, tubulointersti-
tial nephritis and lupus nephritis class V. The data pre-
sented herein demonstrate a decrease of FoxP3? Treg cells
in the inflammatory infiltrate of lupus nephritis, particularly
during the most active phases of lupus nephritis, as ob-
served in the course of a IV class nephritis.
Keywords T reg lymphocytes  FoxP3  Lupus nephritis 
SLE  Glomerulonephritis
Introduction
Lupus nephritis is a common and severe complication of
systemic lupus erythematosus (SLE). A number of patients
have nephritis as a presenting feature that in its severe form
can quickly lead to end-stage renal disease or death [1, 2].
Clinical features of patients with lupus nephritis (LN) range
from asymptomatic urinary microhematuria to macroscopic
hematuria, or proteinuria; from mild to nephrotic levels, or
reduced renal function with rapidly progressive renal failure
and hypertension. Renal biopsy shows histological findings
that demonstrate a spectrum of vascular, glomerular and
tubulointerstitial lesions [2]. LN pathogenesis is attributable
mostly to the glomerular deposition of immune complexes
and overproduction of T helper cytokines. Immune com-
plexes deposits promote the inflammatory response by ac-
tivation of adhesion molecules on endothelium, resulting in
the recruitment of pro-inflammatory leukocytes and devel-
opment of autoimmune injury. Moreover, activated and
damaged glomerular cells, infiltrating macrophages, B and
T cells produce cytokines that play a pivotal role as in-
flammatory mediators to extend renal injury [3–5].
Several potential mechanisms have been reported, in-
volving alterations in T cell receptor and B cell receptor
expressions, postreceptor downstream signaling, which fa-
vor activation of lupus T and B cells. Tyrosine-protein ki-
nase (Syk) is recruited at phosphorylated tyrosines on
immunoreceptors, including the B cell receptor (BCR), T
cell receptor (TCR) The FcRc chain/Syk complex populates
lipid rafts, which are pre-clustered in SLE T cells, and
contribute to the hyperexcitable T cell phenotype found in
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SLE. A series of Janus Kinase/Signal Transducer and Ac-
tivator of Transcription (Jak-STAT) signaling cytokines,
especially type I IFNs, IL-10 and IL-6, as well as the hor-
mone prolactin, have been implicated in the pathogenesis of
SLE. Bruton’s tyrosine kinase (BTK) is a cytoplasmic en-
zyme that is indispensable for signaling through the B cell
receptor. Oral BTK inhibitor improves disease in lupus
prone mice. SLE T cells express increased amounts of nu-
clear CaMKIV (a serine/threonine kinase that is activated
by calcium and then translocates to the nucleus,) which
activates CREMa that binds to interleukin IL-2 promoter
suppressing the transcription of the IL-2 gene. ROCK, a
serine/threonine kinase, which acts downstream of the small
GTPase and RhoA, and regulates cytoskeletal dynamics,
has been implicated in SLE pathogenesis by phosphory-
lating ezrin/radixin/moiesin (ERM) and IRF4. There is a
growing body of evidence that implicates the PI3K pathway
in SLE pathogenesis. Rai, a Shc adapter family member,
acts as a negative regulator of antigen receptor signaling in
T and B cells. RAI (-/-) mice develop lupus like disease
with T CD4? cells polarization to Th17 lymphocytes [6, 7].
Over the past decade, the discovery of new lymphocytes
subtypes revolutionized SLE pathogenesis conception. In
particular, starting from the late 1990s, T lymphocytes with
regulatory properties (T regulatory cells or Tregs) have
been described. It has been shown that Tregs are able to
inhibit T cell proliferation and cytokine production, and
play a critical role in preventing autoimmunity. Tregs play a
central role in the regulation of immune responses to self-
antigens, allergens, and commensal microbiota as well as
immune responses to infectious agents and tumors. Recent
studies suggest that human Treg cells are functionally and
phenotypically diverse. The most studied Tregs sub-
population express specific marker FoxP3 (Forkhead box
P3) which is a protein localized intracellularly that is crucial
for regulatory functions. The complete immunophenotype
of these cells is CD4?, CD25, lowFoxP3? [8–12]. Tregs
involvement in kidney diseases has been studied mostly in
oncology. Studies demonstrate a positive correlation be-
tween Tregs infiltration in kidney specimens and prognosis.
Moreover, Tregs kidney infiltration may be a prognostic
marker of long-term graft function and acute rejection [13,
14]. A number of studies describe Tregs involvement in
SLE pathogenesis. Nevertheless, Tregs’ role in SLE
nephritis remains unknown [15–17].
Materials and methods
Patients and controls
The study was carried out on renal biopsy samples of 29
patients with histologically proven LN, 5 patients with
ANCA-related glomerulonephritis (ANCA-CrGN), 6 pa-
tients with acute tubulointerstitial nephritis (ATIN), and 5
patients with nephroangiosclerosis (NAS). Twenty-nine
Caucasian patients with histologically proven LN classified
according to the ISN/RPS criteria [18] (25 females, 4
males) were enrolled in the study (class III: 5 patients, class
IV: 17 patients, class V: 7 patients). SLE diagnosis was
established according to the 1997 revised American
Rheumatism Association criteria [19]. SLE disease activity
was evaluated using SLEDAI score [20]. The clinical
presentation, 24 h proteinuria, urinalysis, serum creatinine
level, and autoimmunity antibodies were recorded at the
time of biopsy. Of 29 SLE patients, 1 presented neu-
ropsychiatric involvement, 17 had arthralgia, 6 suffered
from serositis and oral ulcers, 7 photosensitivity, 13 pre-
sented skin rashes and 11 cytopenia. None of the patients
had ever received cyclophosphamide, mycophenolate or
rituximab. Other immunosuppressive drugs were suspend-
ed for at least 6 months prior to this study except for
steroid therapy that was maintained at a dose of no more
than 12.5 mg die. At the time of renal biopsy, patients’
features were:
• LN: mean age 35.8 ± 9.3; 25 female, 4 male; serum
creatinine 1.4 mg/dl ± 1.3; mean proteinuria 3.3 g/
24 h ± 1.8; SLEDAI score with a score C6. All
patients had microscopic hematuria.
• ATIN: mean age 56 ± 18.9; 4 female, 2 male serum
creatinine 3.7 mg/dl ± 2.2; mean proteinuria 0.6 g/
24 h ± 0.4; 50 % of patients had microscopic
hematuria.
• ANCA-CrGN: mean age 57 ± 17.2; 3 female, 2 male
serum creatinine 5.1 mg/dl ± 2.5; mean proteinuria
2.6 g/24 h ± 0.7. All patients had microscopic
hematuria.
• NAS: mean age 54 ± 11; 2 female, 3 male serum
creatinine 0.8 mg/dl ± 0.1; mean proteinuria 0.8 g/
24 h ± 0.2. All patients had microscopic hematuria.
Autoimmunity and autoantibodies
ANA
We used ANA-immunofluorescence assay (ANA-IFA) in
which slides prepared from human epithelioid cells (HEp-
2 cells) as a substrate are incubated with diluted serum.
The presence of autoantibodies is detected by fluorescent
anti-immunoglobulin antibody, and characteristic mor-
phologic patterns of fluorescent staining are observed.
Tests were performed using commercial kits by Biomedis
srl (Rome, Italy) according to the manufacturer’s
instructions.
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Anti-dsDNA
We used indirect immunofluorescence assay on Chritidia
Luciliae substrate incubate with diluted serum. Tests were
performed using commercial kits by Biomedis srl (Rome,
Italy) according to the manufacturer’s instructions.
Anti-cardiolipin antibodies IgG and IgM and anti-
beta2GPI
We used EIA commercial kit by DASIT srl (Milano, Italy)
according to the manufacturer’s instructions.
Anti-neutrophil cytoplasmic antibodies
We used commercial immunofluorescence (IF) on ethanol-
fixed neutrophils kit (Biomedis Srl, Roma) according to the
manufacturer’s instructions.
Histology and morphometric analysis
Renal tissue was obtained by percutaneous needle biopsy.
Tissue cylinders were received within 15 min from the
time of biopsy; specimens from each biopsy were divided
into three portions. Two were processed for routine light
and electron microscopic examination; the third fragment
was embedded in OCT and snap-frozen in liquid nitrogen-
cooled isopentane. 3 to 4 sections from paraffin-embedded
blocks were routinely stained with hematoxylin-eosin, PAS
and Periodic acid-silver methenamine (PASM) 5 sections
from OCT-embedded tissues were cut in a cryostat,
brought to phosphate buffered saline PBS, and stained with
FITC-conjugated antibodies against human IgA, IgG, IgM,
C3c, C1q, Fibrinogen and Kappa and Lambda light chains
(Dako Corporation, Glostrup, Denmark). The severity of
glomerular, tubulointerstitial and vascular lesions was
evaluated according to the standard histological classifi-
cation of LN, and the corresponding histological class was
assigned to each case [18].
Immunohistochemistry was then performed by the
streptavidin–biotin method onto additional sections ob-
tained from the paraffin-embedded tissues, using the fol-
lowing primary antibodies:
1. Monoclonal antibody against FoxP3 (Abcam Inc,
Cambridge, UK).
2. Monoclonal antibody against CD3 (Dako Corp.,
Glostrup, Denmark).
Adjacent sections were cut from each block, and col-
lected on two slides; immunostaining for each of the two
antibodies was therefore performed in each case. Briefly,
endogenous peroxidase was blocked by incubation with
3 % hydrogen peroxide, and primary antibodies were used
at a concentration of 25 lg/mL. Sections were then incu-
bated with LSAB2 (Dakocytomation) 3-30-diaminoben-
zidine (DAB) was used for color development, and
haematoxylin was used for counterstaining. Negative
controls were obtained by omitting primary antibodies.
Digital images from the immunostained slides were
obtained using ScanScope Digital Slide Scanner (Aperio,
Vista, CA, USA) at a 409 magnification. Quality control of
the scanned images and all further analysis were performed
using ImageScope software V10.2.1.2315 (Aperio). Slides
were analyzed by using the Positive Pixel Count Algorithm
v9, which counts pixels of predetermined color, intensity
and saturation; each slide was separately analyzed using
the default set of parameters. An algorithm output provided
a number of 1?, 2? and 3? intensity positive pixels, and
the number of total pixels in each annotated layer. The total
number of pixels consisted of positive and negative pixels
excluding the white area of the virtual slides (i.e., the
center of tubules, vacuoles, Bowman’s capsule space).
Since 1? pixel areas were mostly picking-up weak back-
ground staining but not FoxP3 or CD3 immunostaining,
only 2? and 3? areas were regarded as positive for further
analysis; the pixel number was then normalized by the
whole kidney section area. By this method, it was possible
to obtain (1) the number of FoxP3-positive and CD3-
positive cells in each case, and (2) the ratio of FoxP3-
positive CD3 cells in each case (Figs. 1, 2).
The study was approved by the Local Ethics Committee
Directives of Clinical Medicine Department of Sapienza
University of Rome.
Results
Demographics
The demographic parameters of the samples, at the time of
renal biopsy, are reported in Table 1.
CD3? lymphocytes expression
In sections examined, the number of CD3? lymphocytes
was significantly higher in patients with acute tubu-
lointerstitial nephritis (ATIN) (5713/mm2) and ANCA
crescentic glomerulonephritis (CrGN) (5121/mm2,) com-
pared to patients with LN class IV (3558/mm2), LN class
III (2491/mm2), nephroangiosclerosis (NAS) (2379/mm2)
and LN class V (2220/mm2), p\ 0.05.
In particular, we found no statistically significant dif-
ferences in the expression of CD3 ? cells among the three
classes of LN.
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Fig. 1 a CD3? cells in section of patient with NAS. CD3 infiltration is
expressed by a chromatic scale: high-infiltration (brown), medium-
infiltration (orange), low-infiltration (yellow), negative (blue).b FoxP3?
cells in section of patient with NAS. FoxP3 infiltration is expressed by a
chromatic scale: high-infiltration (brown), medium-infiltration (orange),
low-infiltration (yellow), negative (blue) (color figure online)
Fig. 2 a CD3? cells in section of patient with class IV LN. CD3
infiltration is expressed by a chromatic scale: high-infiltration
(brown), medium-infiltration (orange), low-infiltration (yellow),
negative (blue). b FoxP3? cells in section of patient with class IV
LN. FoxP3 infiltration is expressed by a chromatic scale: high-
infiltration (brown), medium-infiltration (orange), low-infiltration
(yellow), negative (blue) (color figure online)
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FoxP3? lymphocytes expression
Considering the totality of patients with LN (LN-IV, LN-V,
LN-III together) we find a significant reduction in the ratio
FoxP3? cells/CD3? cells in SLE compared to subjects
with ATIN and NAS, p\ 0.05. The difference of the ratio
FoxP3? cells/CD3? cells between SLE and ANCA-CrGN
is not statistically significant.
We observe a statistically significant reduction of the
ratio FoxP3?/CD3? in LN-IV compared to NAS, to ATIN
and to LN-V; p\ 0.05 for LN-IV vs NAS, ATIN, LN-V;
p = ns for LN-III and LN-IV vs ANCA-CrGN.
Discussion
SLE pathogenesis is a complex process involving both
innate and adaptive immunity, and both humoral and cel-
lular immune compartments. Literature data, derived from
in vitro studies, works on mouse models and human re-
search, demonstrate the centrality of lymphocyte dys-
regulation in SLE pathogenesis. In recent years, to the
duality T lymphocytes–B lymphocytes, in part focused on
Th1/Th2 paradigm, were added new lymphocyte me-
diators, leading to a revolution in the concepts of the au-
toimmune diseases pathogenesis [21, 22]. The discovery of
Table 1 The demographic
parameters of the samples, at
the time of renal biopsy
LN ANCA-CrGN ATIN NAS
N 27 3 6 2
Age (years) (mean ± SD) 35.8 ± 9.3 57 ± 17.2 56 ± 18.9 54 ± 11
Systolic blood pressure (mmHg) (mean ± SD) 130 ± 15 140 ± 16 135 ± 14 145 ± 20
Diastolic blood pressure (mmHg) (mean ± SD) 85 ± 5 90 ± 8 90 ± 6 90 ± 8
BMI (kg/m2) (mean ± SD) 24.6 ± 4 23.9 ± 3 23 ± 3.5 24.5 ± 3.6
Smokers (%) 0 0 0 0
Hypertension (ESC criteria) (%) 37 33 50 50
Dyslpidemia (ATPIII/NCEP criteria) (%) 29.6 33 33.3 50
Type 2 diabetes (ADA criteria) (%) 0 0 0 0
CAD history (AHA criteria) (%) 0 0 0 0
Disease duration (years) (mean ± SD) 8.1 ± 2.3
SLEDAI pt (mean ± SD) 14 ± 4
Therapy (%)
CCS per os 44
CCS ? HCQ 55.5
CCS ? CyA 0
CCS ? AZA 0
CCS ? MTX 0
CCS ? MFM 0
CCS ? CyC 0
Rituximab 0
Therapy history (%)
CCS bolus 3.7
CyC bolus 0
Rituximab 0
ANA C 1:160 (%) 100 0 0 0
Anti-dsDNA (%) 55.5 0 0 0
ENA Sm (%) 37.3 0 0 0
ANCA (%) 0 100 0 0
LAC (%) 0 0 0 0
Anti-phospholipids (%) 0 0 0 0
Hematuria (%) 100 100 50 100
Proteinuria 24 h (g/L) (mean ± SD) 3.3 ± 1.8 2.6 ± 0.7 0.6 ± 0.4 0.8 ± 0.2
Serum creatinine (mg/dl) (mean ± SD) 1.4 ± 1.3 5.1 ± 2.5 3.7 ± 2.2 0.8 ± 0.1
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Foxp3 as a specific intracellular marker of T lymphocytes
with regulatory function (Tregs) gave, over the past dec-
ade, a new push to research on immuno-regulation [23].
Tregs, and in particular the Tregs with phenotype CD4?
CD25 high? FoxP3?, play a crucial role in maintaining
immune homeostasis, ensuring tolerance towards self-
antigens, and modulating inflammatory responses towards
exogenous antigens and to allergens [24]. LN is one of the
most serious manifestations of SLE. Recent evidence
suggests a possible involvement of Tregs in LN. In a study
of human LN, levels of circulating Tregs and the expres-
sion of serum and urinary TGF-b1 were assessed. This
study demonstrates a significant reduction in the frequency
of CD4? CD25 high and CD4? CD25? FoxP3? with
respect to the total CD4? T lymphocytes in patients with
LN. The decreased Tregs count is accompanied by low
serum levels and increased urinary levels of TGFb1. In
NZB/NZWF1 mice, the depletion of CD4? CD25? ac-
celerates the development of membrano-proliferative
glomerulonephritis. The adoptive transfer of CD4?
CD25? in knock-out mice for these lymphocytes retards
the development of proliferative glomerular lesions [12,
15–17, 25]. To date, this is the first study targeted to ana-
lyze the Tregs expression in the inflammatory infiltrate of
LN renal biopsies, using FoxP3 as Tregs marker. In order
to assess the comparative expression of FoxP3 in SLE
patients we used subjects with different type of kidney
disease: ANCA-CrGN, ATIN and NAS as a control sam-
ple. In addition, we evaluated the differences in FoxP3
expression in the context of different LN classes. The use
of a heterogeneous control group has allowed us to com-
pare the patients with SLE in three different conditions:
nephropathy based on chronic inflammatory status as
ANCA-CrGN, nephropathy based on toxic or infectious
trigger, and nephropathy based on degenerative process. In
line with the literature data regarding the magnitude of the
inflammatory infiltrate in nephritis, we find a high ex-
pression of CD3? cells in patients with ATIN, and to a
lesser extent in patients with ANCA-CrGN, compared to
patients with LN and NAS. In fact, ATIN, caused by toxic
or infectious agents, and renal vasculitis are characterized
by an abundant inflammatory infiltrate. Among the LN
classes, the patients with class IV have a greater inflam-
matory infiltrate than the class V and class III. In fact, in
the class IV, the development of glomerulo-proliferative
lesions is supported by a significant inflammatory
stimulation [18, 26]. Tregs play an important role in the
maintenance of immune tolerance to self, and inhibit the
development of SLE [27]. FoxP3? Tregs are significantly
decreased, accompanied by increased in Th17 cells in LN
patients, suggests that Th17/Treg functional imbalance
may be involved in the pathogenesis of renal damage in
SLE patients [28]. In lupus nephritis biopsy, we find
reduced FoxP3? Tregs in relation to the total number of
lymphocytes of the inflammatory infiltrate (expressed as a
ratio cells of FoxP3?/CD3?) Moreover, in our paper we
describe a minimal FoxP3? Tregs expression in class IV
lupus nephritis. We describe only quantitative data, and
cannot analyze the inhibitory properties of FoxP3? Tregs.
However, we speculate that a numerical hypo-expression
of FoxP3? Tregs in class IV lupus nephritis may take part
in the immunological dysregulation leading to a glomerulo-
proliferative pattern typical of class IV lupus nephritis.
Considering overall LN patients, we find a reduced
Tregs number in relation to total lymphocytes of the in-
flammatory infiltrate (expressed as a ratio cells of FoxP3?/
CD3?) compared to ATIN and NAS. We find no differ-
ences between LN and ANCA-related glomerulonephritis.
These findings might suggest that a deficiency of Tregs
may facilitate inflammatory glomerular damage based on
autoimmune process (such as LN) and this might be ir-
relevant in inflammatory conditions based on infectious or
toxic trigger. To further confirm this speculation, our data
show that the Tregs expression is minimal in LN class IV
compared to LN class III and V. In fact, the LN class IV is
characterized by an inflammatory infiltrate more intense
and active than other classes. According to literature data,
it is possible to speculate about a role of FoxP3? Tregs in
autoimmune nephropathies, and in particular, in LN. A
deficit of FoxP3? Tregs may facilitate the processes of
organ damage on an autoimmune basis, and be crucial in
determining proliferative glomerular lesions, as seen in LN
class IV. It should be emphasized that this is a preliminary
study. The small sample size does not allow further ana-
lysis. The results need to be confirmed and validated in a
study with an appropriate simple size and perhaps in a
longitudinal study relating the Tregs infiltration with the
renal outcome of LN patients.
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